Log in or Sign up for Free to view tailored content for your specialty!
Osteoarthritis and Bone Disorders News
Jump training after ACL reconstruction reduced secondary injury, OA risk factors
Athletes who underwent jump training after ACL reconstruction reduced some risk factors for secondary injury and osteoarthritis, while making lasting improvements in physical function measures and mechanical and neuromuscular coordination deficits, according to results published in The American Journal of Sports Medicine.
Ace the Case: A 60-Year-Old-Man With Worsening Chronic Right Knee Pain
A 60-year-old man presents with worsening chronic right knee pain.
Log in or Sign up for Free to view tailored content for your specialty!
Johns Hopkins named top hospital for rheumatology care by U.S. News & World Report
Johns Hopkins Hospital has been recognized by U.S. News & World Report’s Best Hospitals Survey as the top-ranked hospital in the country for rheumatology for the 2018 to 2019 year.
Medial knee load strongly linked to increased walking knee pain
Medial knee load is strongly associated with increased knee pain experienced during walking, according to findings published in Arthritis Care & Research.
RA prevalence in Latin American indigenous community among highest worldwide
More than one-third of indigenous people in Latin America have a musculoskeletal disorder, and the prevalence of rheumatoid arthritis in these communities — particularly the Qom in Argentina — is among the highest reported in the world, according to findings published in the Annals of the Rheumatic Diseases.
EULAR recommends physical activity as part of standard care for inflammatory arthritis, OA
Physical activity should be an integral part of standard care in the treatment of inflammatory arthritis and knee and hip osteoarthritis, and all health care providers should take responsibility for promoting its use, according to recommendations released by EULAR.
Pfizer, Eli Lilly and Company announce positive outcomes with OA treatment
Pfizer Inc. and Eli Lilly and Company announced that a 16-week phase 3 study showed patients with osteoarthritis who received two doses of tanezumab, an investigational humanized monoclonal antibody, separated by 8 weeks had a statistically significant improvement in pain, physical function and the patients’ overall assessment of their OA.
Use of hyaluronic acid for knee OA may yield cost savings
BARCELONA, Spain — Use of hyaluronic acid as conservative treatment for patients with knee osteoarthritis had a potential cost savings of $1.5 billion, according to results presented here.
Distinguishing ‘Stem Cell Hype’ From Hope in Knee Osteoarthritis
In early May, the FDA filed two federal complaints seeking to permanently ban two stem cell clinics from marketing stem cell products without regulatory approval, accusing these clinics of disregarding “the law, and more importantly, patient safety.”
Ace the Case: A 64-Year-Old Man with Painful Knee Osteoarthritis Who Does Not Want a Total Knee Arthroplasty
Your patient has returned to your clinic 1 month after right knee intra-articular corticosteroid injection for an acute flare of his osteoarthritis.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read